Searched for
MYLAN PHARMACEUTICALS INC
Natco Pharma's partner MylanInc gets USFDA nod for cancer drugThe company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).03 Jun, 2016, 02.52 PM IST- Sandoz Inc, Macleods Pharma recall two drugs made in IndiaUS drug firm Sandoz Inc is recalling over 2,70,000 bottles of hypertension tablets, manufactured by Hyderabad-based Mylan Laboratories.22 Feb, 2016, 10.25 PM IST
- Teva offers to buy Mylan for $40.1 billionTeva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.22 Apr, 2015, 04.42 AM IST
- Natco Pharma's US partner Mylan files application with USFDANatco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly ...11 Feb, 2015, 10.53 PM IST
- Mylan-Abbott deal gets CCI green signalThe CCI observed that "there is horizontal overlap" between the pharmaceutical products of Mylan and Abbott in India with respect to certai...24 Nov, 2014, 07.23 PM IST
- Mylan launches breast cancer drug in IndiaDrug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.03 Feb, 2014, 08.41 PM IST
- Indian companies in FDA's first list for generic Aciphex tabletsIndian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic vers...10 Nov, 2013, 01.03 PM IST
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...03 Sep, 2013, 08.06 PM IST
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...27 Aug, 2013, 06.29 PM IST
- UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.22 Jul, 2013, 02.53 PM IST
- Lupin falls nearly 5% on Mylan drug launch, Credit Suisse downgradeCredit Suisse downgraded Lupin from ‘outperform’ to ‘neutral’ rating and upped the price target from Rs 710 earlier to Rs 755.20 May, 2013, 11.07 AM IST
- Pfizer files patent suit against Lupin, 5 other pharma firmsUS-based pharma giant Pfizer Inc today said it has filed suit against six firms, including India's Lupin, over patent infringement of celec...05 Mar, 2013, 10.04 PM IST
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...05 Aug, 2012, 12.08 PM IST
- Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...20 Jul, 2012, 03.58 PM IST
- Natco Pharma loses patent case against Teva Pharmaceutical Industries of anti-sclerosis drugNatco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...25 Jun, 2012, 04.27 PM IST
- Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US marketDr Reddy's Laboratories announced today that it has launched Clopidogrel tablets, USP, a bioequivalent generic version of Plavix in the US ...18 May, 2012, 06.20 PM IST
- Natco inks agreement with Mylan for CopaxoneHome grown major Natco Pharma today said it has signed a licence and supply agreement with US-based Mylan for the global sale of generic ve...10 Jun, 2008, 08.38 PM IST
Load More
